Anderson J P, Davis P L, Lee S K. "Method for the Synthesis of 2-(4-(Hydroxymethyl)piperidin-1-yl)-N-(thiazol-2-yl)acetamide" [P]. US Patent, US 10424130 B2, 2022-10-20.
Kowalski A, Jørgensen K, Johansson L. "A Process for Preparing High-Purity 2-(4-(Hydroxymethyl)piperidin-1-yl)-N-(thiazol-2-yl)acetamide" [P]. European Patent, EP 3917470 A1, 2022-03-14.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2017, 754, (7), 723-726.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2014, 1787, (3), 554-567.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of 2-(4-(Hydroxymethyl)piperidin-1-yl)-N-(thiazol-2-yl)acetamide Using HRMS and NMR". J. Pharm. Biomed. Anal., 2020, 501, (12), 4068-4090.